Biochip Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology (Microarray v/s Microfluidics), By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, In-vitro diagnostics, Others), By End User (Hospitals & Diagnostics Centers, Academic & Research Institu
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationBiochip Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology (Microarray v/s Microfluidics), By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, In-vitro diagnostics, Others), By End User (Hospitals & Diagnostics Centers, Academic & Research Institu
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 14.96 Billion |
| CAGR (2023-2028) | 14.09% |
| Fastest Growing Segment | Drug Discovery & Development |
| Largest Market | North America |
Market Overview
Global Biochip Market has valued at USD 14.96 Billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 14.09% through 2028. Biochips are miniature medical devices designed to perform multiple biochemical reactions simultaneously, reducing the required time. They consist of micro-test sites or microarrays arranged on a solid substrate. Biochips are found at in various forms, including DNA, protein, enzyme, and lab-on-a-chip. These compact and powerful devices are user-friendly and provide accurate critical insights. They are particularly suitable for storing personal medical and financial information and can be used for tracking individuals. Implanted in the body, biochips assist in monitoring, analyzing, and controlling patient health and biological processes. Additionally, they contribute to hazard identification, ensuring a safe environment, and improving decision-making. Consequently, biochips have widespread applications in gene, oncology, and inflammatory diagnosis, as well as molecular analysis worldwide.
Key Market Drivers
Growing Use of Biochips in Personalized Medicine
Biochips play a crucial role in point-of-care diagnosis and molecular diagnostics, driving high demand for their application in personalized medicine. These chips prove invaluable in distinguishing between normal and cancerous cells, enabling rapid analysis of the entire proteome for protein-based therapeutics. Moreover, they serve as reliable tools for detecting a wide range of biomarkers with limited sample quantities, offering immense potential in disease diagnosis and treatment. Consequently, the demand for biochips in personalized medicine continues to soar.
The use of Biochips in molecular diagnostics and point-of-care diagnosis is expected to create a significant demand for these chips in advancing customized medicine. These innovative chips play a crucial role in accurately identifying and differentiating between healthy and malignant cells' proteins, providing valuable insights for protein-based treatments. One of the key advantages of Biochips is their ability to facilitate a comprehensive study of the complete proteome in a quick and efficient manner. Their high demand in personalized medicine stems from their reliability in identifying a wide range of indicators using a limited number of samples, while also offering the potential for effective diagnosis and treatment of various conditions. With their unique capabilities, Biochips are poised to revolutionize the field of personalized medicine and contribute to the advancement of tailored healthcare solutions.
Increased Technological Advancement
The use of Biochips in proteomics has significantly increased alongside technological advancements. With the progress in nanotechnology, Biochips have become even more valuable due to their enhanced functionality, reduced size, and wider range of applications. They are now extensively utilized in diagnostics, research, medication development, and toxicological studies. These versatile chips find applications in genotyping, peptides, customized medicine, and various other fields, which has fostered the emergence of new technologies by both established manufacturers and young entrepreneurs. As the demand for Biochips continues to grow, the market is witnessing a surge in innovative products and funding for research and development.
Increasing Demand for Point-of-care Testing
The increasing demand for point-of-care (POC) testing is poised to have a significant positive impact on the demand for biochips in the field of diagnostics and healthcare. POC testing refers to diagnostic tests that are conducted near the patient, often at the bedside or in outpatient settings, providing rapid results without the need for centralized laboratory facilities. Biochips, also known as microarrays, are a key enabler of POC testing due to their versatility, efficiency, and suitability for miniaturized, high-throughput diagnostic applications.
POC testing can enhance access to healthcare services, particularly in underserved or remote areas with limited access to centralized laboratories. Biochip-based POC tests are portable and can be used in resource-limited settings. Biochips enable the profiling of individual patient biomarkers, allowing for personalized treatment plans tailored to a patient's unique genetic makeup, which is a cornerstone of modern medicine.
The increasing demand for POC testing, driven by the need for faster, more convenient, and personalized diagnostics, is expected to boost the demand for biochips. As biochip technology continues to evolve and adapt to emerging healthcare challenges, it is poised to play a pivotal role in transforming the landscape of healthcare diagnostics and improving patient care globally.
Increasing Application of Proteomics and Genomics in Cancer Research
The increasing application of proteomics and genomics in cancer research is poised to significantly boost the demand for biochips, revolutionizing the way cancer is diagnosed, characterized, and treated. Biochips, also known as microarrays, serve as powerful tools in this endeavor due to their ability to simultaneously analyze thousands of genes or proteins in a single experiment. Identifying reliable biomarkers for early cancer detection, prognosis, and treatment response is essential. Biochips enable researchers to screen large numbers of potential biomarkers quickly and efficiently, accelerating the discovery of novel markers with diagnostic and therapeutic significance.
Biochips play a vital role in drug discovery and development. They facilitate the screening of compounds or therapeutic agents against cancer-related proteins or genes, helping identify potential drug candidates and advancing the development of targeted therapies. Biochips enhance research efficiency by enabling researchers to analyze multiple genes or proteins simultaneously, reducing the time and resources required for comprehensive cancer studies.
The demand for biochips is expected to grow in tandem with the expanding scope of cancer research and the increasing recognition of the value of proteomics and genomics in understanding the molecular intricacies of cancer. As precision medicine becomes more commonplace in oncology, biochips will continue to play a pivotal role in advancing our knowledge of cancer biology and improving patient outcomes through more targeted and effective treatments.
Key Market Challenges
High Chances of Biohacking and Privacy Concern
Biochips, tiny devices inserted into the hands, have revolutionized daily routines by expediting tasks. These cutting-edge chips offer a multitude of benefits, such as seamless access to homes, gyms, and offices, along with the convenience of storing emergency contacts, social media profiles, and e-tickets. Notably, Sweden has witnessed a surge in individuals opting to have these microchips implanted in their hands. However, scientists have raised concerns regarding potential data breaches and hacking vulnerabilities associated with biochips. These chips have the capability to track locations, monitor spending habits, and even record driving behaviors, making them susceptible to unauthorized access. Moreover, the presence of chips inside the body poses infection risks and raises questions about individual freedom. In response to these concerns, the United States has recently implemented regulations to prohibit the forced usage of biochips. It is anticipated that the market's revenue growth may face constraints due to the risks of biohacking and privacy concerns. The need for enhanced security measures and addressing privacy issues is crucial for the sustainable growth of this innovative industry.
High Cost and Lack of Awareness Regarding Biochips
The development of bio-chip technology is a highly cost-intensive process. It requires extensive research and development efforts, as well as skilled developers, which ultimately contributes to the high cost of the end-product. The biochip system itself consists of microscale probes that are carefully formatted on glass surfaces. These microscale samples require precise handling and scanning, which necessitates the use of automated robotic instruments. The complexity and specificity of the methodologies and tools required for implementing this technology also contribute to its high cost.
Key Market Trends
Increasing Adoption of Biochips For Detecting Allergies
Many individuals have encountered various types of allergies, such as food, pollen, and others, resulting in a range of symptoms including fever, skin reactions, vomiting, asthma, and diarrhea. To address these issues, the field of allergy testing has witnessed the emergence of a remarkable new technology known as allergy testing biochips. This technology is currently experiencing significant growth and involves the use of microarrays that contain different allergen components. By utilizing these biochips, healthcare professionals are able to investigate patient-specific sensitization patterns in a single measurement, thus enhancing the accuracy and efficiency of allergy diagnoses.
Furthermore, the potential of biochips in allergy research has prompted companies to invest in the development of new technologies. For example, in April 2021, Toray Industries made an announcement regarding the successful development of allergy testing biochips capable of detecting multiple allergen-specific immunoglobin E (IgE) antibodies from trace amounts of blood. This breakthrough innovation holds tremendous promise for improving the precision and effectiveness of allergy testing.
Growing Usage of Biochips in Diverse Areas
Biochip technologies are extensively utilized across a range of fields, including microbiology, DNA analysis, clinical pathology, pharmacology, proctology, and biochemistry, among others. Ongoing research endeavors will drive the adoption of biochip technologies, particularly in the healthcare industry, thus further expanding their usage in the mainstream market in the coming years. Biochip technology is also employed in sequence engineering, which is poised to boost the growth of the global biochip market and enhance the performance and scalability of biochip solutions. Manufacturers of biochips are focusing on innovating distinct aspects of their miniature laboratories that can effectively function with living organisms.
Biochips have emerged as a pivotal component in revolutionizing DNA sequencing technology. Moreover, they are likely to pave the way for advanced gene sequencing solutions. The integration of gene sequencing technology and biochips will address various biological tissues, enabling rare cell, single-cell, and red molecule analysis. Nevertheless, the continuous growth of biochip technology and its expanding throughput capacity are expected to broaden its applications, ranging from population-centric clinical studies to the detection of rare bacteria. Manufacturers are making substantial investments in biochips for single-cell analysis, which will contribute to the improvement of biochips and their versatile functions, consequently enhancing performance exponentially.
Segmental Insights
Type
The global biochip market is categorized into various types, including DNA chip, lab-on-a-chip, protein chip, and others. Among these, lab-on-a-chip is projected to exhibit a rapid revenue growth rate during the forecast period. This can be attributed to the high demand for biochips in diverse applications such as proteomics, cell biology, molecular biology, chemistry, and others. Lab-on-chip devices offer multiple advantages, including cost efficiency, high parallelization, low volume reagents, high expandability, and high sensitivity. These factors are anticipated to drive the growth of the lab-on-chip segment. Moreover, lab-on-chip technology plays a crucial role in biomedical diagnostics and analytical chemistry. Additionally, the bimolecular operations performed in lab-on-chips enable ultra-fast virus and bacteria detection, making it highly valuable for molecular biology.
Application Insights
Based on application, the global biochip market is categorized into Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, In-vitro diagnostics, and Others. The In-vitro diagnostics segment is projected to hold a significant revenue share over the forecast period, driven by the increasing demand for biochips in In-Vitro Diagnostics (IVD). This includes applications such as DNA analysis, lab-on-chip technology, protein microarrays, and other array applications. Biochips also find utility in other IVD solutions like toxio-genomics and High Throughput Screening. For example, in January 2022, researchers from the Universidad Politécnica de Madrid (UPM) and the Universidad Carlos III de Madrid (UC3M) developed a biochip that simplifies the manufacturing process of in-vitro skin and other multilayer tissues in a laboratory setting.
Regional Insights
North America dominates the market throughout the projection period, primarily due to the government's concerted efforts to boost R&D through tax incentives. This region is expected to maintain its industrial position, thanks to its high concentration of biotechnology businesses, academic and research organizations, and projected future technological advancements in Biochip applications. The Asia-Pacific regional market, on the other hand, is poised for tremendous growth, driven by China and India. Expanding access to new technologies, a sizable patient base, advancements in the healthcare system, and the increasing utilization of Biochip technology are key factors influencing the region's expansion. Mature businesses are delegating Biochip production to emerging economies, aiming to reduce overall costs.
Recent Developments
- October 2022MicrobioSeq(CD Genomics) unveiled the Phage Whole-Genome Sequencing service, facilitatingbiomarker discovery and the development of non-antibiotic treatment methods. CDGenomics utilizes cutting-edge next-generation sequencing and long-readsequencing technologies (primarily Illumina HiSeq, Nanopore, and PacBio SMRTsequencing) to offer comprehensive virus/phage sequencing services, enablingin-depth studies of structural genomics and comparative genomics.October 2022Thermo FisherScientific Inc. enhanced its Applied Biosystems Chromosome Analysis Suite(ChAS) software through a strategic collaboration with Genoox, acommunity-driven genomic data company. ChAS users now have access to Genoox'scloud-based AI platform. With automated interpretation and reporting, ChAS withFranklin provides an intuitive and flexible workflow, ensuring instant accessto consistent and reproducible cytogenetic analysis results.March 2022NutcrackerTherapeutics secured $167 million in Series C financing to advance its RNAplatform and expand its mRNA pipeline. Nutcracker is committed to thedevelopment of RNA therapeutics leveraging its biochip-based manufacturingplatform. The company anticipates that the funding, led by ARCH VenturePartners, will enable the expansion of its mRNA treatment pipeline for cancerand further enhancement of its platform technology.
Key Market Players
- Abbott Laboratories Inc.
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Fluidigm Corporation
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Illumina Inc.
- Phalanx Biotech Group Inc.
- BioMerieux SA
- Qiagen NV
| By Technology | By Type | By Application | By End User | By Region |
|
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy